Leeward Investments LLC MA Sells 14,308 Shares of Option Care Health, Inc. $OPCH

Leeward Investments LLC MA decreased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 3.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 371,365 shares of the company’s stock after selling 14,308 shares during the quarter. Leeward Investments LLC MA owned approximately 0.23% of Option Care Health worth $12,062,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. USA Financial Formulas bought a new position in shares of Option Care Health during the second quarter valued at $26,000. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after acquiring an additional 836 shares in the last quarter. Brooklyn Investment Group increased its holdings in shares of Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock valued at $42,000 after acquiring an additional 780 shares in the last quarter. Bessemer Group Inc. increased its holdings in shares of Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after acquiring an additional 599 shares in the last quarter. Finally, Wealthquest Corp bought a new position in shares of Option Care Health during the first quarter valued at $66,000. 98.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

OPCH has been the subject of several analyst reports. Morgan Stanley initiated coverage on Option Care Health in a report on Friday, October 17th. They set an “overweight” rating and a $35.00 price target for the company. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Cowen initiated coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating on the stock. TD Cowen initiated coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating and a $30.00 price objective on the stock. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Tuesday, September 23rd. Nine research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $35.10.

Insider Activity

In related news, Director Timothy P. Sullivan acquired 20,000 shares of the stock in a transaction dated Thursday, August 21st. The shares were purchased at an average cost of $27.51 per share, with a total value of $550,200.00. Following the transaction, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the stock in a transaction dated Wednesday, August 20th. The shares were bought at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the transaction, the director owned 375,390 shares in the company, valued at approximately $10,191,838.50. This represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 59,411 shares of company stock valued at $1,627,576 in the last ninety days. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Trading Down 0.5%

Shares of NASDAQ:OPCH opened at $27.91 on Friday. The stock has a market capitalization of $4.53 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 1.69 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock’s 50-day simple moving average is $27.99 and its two-hundred day simple moving average is $30.09. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same period in the previous year, the firm earned $0.30 EPS. The business’s quarterly revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.